Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease
25 August 2023 (07:30 - 18:30)
Organised by: 

About the speaker

Emory Clinical Cardiovascular Research Institute, Atlanta (United States of America)
6 More presentations in this session
Professor B. Kingwell (Melbourne, AU)
Doctor A. Kallmeyer (Madrid, ES)
Access the full session
The Event
ESC Congress 2023
25 August - 28 August 2023
You may be interested in
Congress Presentation
